Filing Flows › VitaNova Life Sciences (VNOV) › Q4 FY26
VitaNova Life Sciences (VNOV) Q4 FY26 earnings results (fourth quarter fiscal 2026)
10-K filed Jul 29, 2026
VitaNova Life Sciences (VNOV) reported revenue of $1.8M for the fourth quarter fiscal 2026 (Q4 FY26), -9% from a year earlier and +152% from the quarter before. Operating margin was -6.2%, net earnings $18K (1.0% of revenue).
VitaNova Life Sciences, Q4 FY26: revenue $1.8M (-9% year over year), operating margin -6.2%, net earnings $18K, operating cash flow $428K. The chart follows the revenue to costs, profit and cash.
| Q4 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | +152% | -9% |
| Operating profit | −$110K | -335% | -110% |
| Net earnings | $18K | — | -98% |
| Operating cash flow | $428K | — | -11% |
What changed
Revenue was $1.8M in Q4 FY26, down 9% year over year and up 152% from the previous quarter.
Gross margin was 14.8%, down 44.4 points from Q4 FY25. Operating costs exceeded revenue by $110K, an operating margin of -6.2%. Operating expenses grew 398% against a revenue fall of 9%. The fastest-growing cost line was General & admin (+1003%). Net earnings were $18K, down 98% year over year.
Operating cash flow was $428K (down 11% year over year), 2441% of net earnings. Non-cash charges added back $179K of share-based compensation. Working capital and other items added $231K.
Questions
What was VitaNova Life Sciences' revenue in the fourth quarter fiscal 2026?
VitaNova Life Sciences (VNOV) reported revenue of $1.8M for the fourth quarter fiscal 2026 (Q4 FY26), -9% from a year earlier and +152% from the quarter before.
Was VitaNova Life Sciences profitable in the fourth quarter fiscal 2026?
Operating loss was $110K (-6.2% of revenue) and net earnings $18K.